Drugs / [11C]Cimbi-36
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02629003 Comparator | Dec 2015 → Oct 2018 | — | Gitte Moos Knudsen | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [11C]Cimbi-36 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02629003 ↗ |
| Modality | Diagnostic / imaging agent | “Positron Emission Tomography (PET) tracer” NCT02629003 ↗ |
| Route | Intravenous | “single dose intravenous (I.V.)” NCT02629003 ↗ |